AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 63 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,646,000 | -62.2% | 461,726 | -41.0% | 0.01% | -57.7% |
| Q4 2020 | $6,993,000 | +30.2% | 782,183 | +69.6% | 0.03% | +23.8% |
| Q3 2020 | $5,370,000 | -31.0% | 461,324 | -5.0% | 0.02% | -38.2% |
| Q2 2020 | $7,785,000 | +729.1% | 485,624 | +209.8% | 0.03% | +466.7% |
| Q1 2020 | $939,000 | -54.6% | 156,773 | 0.0% | 0.01% | -45.5% |
| Q4 2019 | $2,069,000 | +6.3% | 156,773 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $1,947,000 | -22.9% | 156,773 | 0.0% | 0.01% | -23.5% |
| Q2 2019 | $2,524,000 | -48.8% | 156,773 | 0.0% | 0.02% | -46.9% |
| Q1 2019 | $4,934,000 | -4.2% | 156,773 | 0.0% | 0.03% | -23.8% |
| Q4 2018 | $5,148,000 | -28.7% | 156,773 | -33.4% | 0.04% | -12.5% |
| Q3 2018 | $7,216,000 | +14.5% | 235,294 | 0.0% | 0.05% | +2.1% |
| Q2 2018 | $6,304,000 | – | 235,294 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |